AbbVie Inc.
Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%
AbbVie Qulipta (atogepant) by Quarter
Qulipta (atogepant) — Worldwide operational (constant-currency) growth YoY (%) (%)
AbbVie Qulipta (atogepant): 30.3% in Q2 2026, down 46.6 pts from a year earlier. That is the lowest of the 10 quarters on record here.
Where the Q2 2026 figure comes from
“| 30.9 | 95.9 | 30.3”
Source: Form 8-K (abbv-20260630xexhibit991.htm, filed 2026-07-31) ↗
Reported in Form 8-K Key Product Revenues Schedule.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Qulipta (atogepant) — Worldwide operational (constant-currency) growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 30.3% | -46.6 pts | Form 8-K (abbv-20260630xexhibit991.htm, filed 2026-07-31) ↗ |
| Q1 2026 | Mar 31, 2026 | 51.3% | +3.0 pts | Form 8-K (abbv-20260331xexhibit991.htm, filed 2026-04-29) ↗ |
| Q4 2025 | Dec 31, 2025 | 41.8% | -34.4 pts | Form 8-K (abbv-20251231xexhibit991.htm, filed 2026-02-04) ↗ |
| Q3 2025 | Sep 30, 2025 | 63.1% | +29.5 pts | Form 8-K (abbv-20250930xexhibit991.htm, filed 2025-10-31) ↗ |
| Q2 2025 | Jun 30, 2025 | 76.9% | +20.6 pts | Form 8-K (abbv-20250630xexhibit991.htm, filed 2025-07-31) ↗ |
| Q1 2025 | Mar 31, 2025 | 48.3% | -49.4 pts | Form 8-K (abbv-20250331xexhibit991.htm, filed 2025-04-25) ↗ |
| Q4 2024 | Dec 31, 2024 | 76.2% | – | Form 8-K (abbv-20241231xexhibit991.htm, filed 2025-01-31) ↗ |
| Q3 2024 | Sep 30, 2024 | 33.6% | – | Form 8-K (abbv-20240930xexhibit991.htm, filed 2024-10-30) ↗ |
| Q2 2024 | Jun 30, 2024 | 56.3% | – | Form 8-K (abbv-20240630xexhibit991.htm, filed 2024-07-25) ↗ |
| Q1 2024 | Mar 31, 2024 | 97.7% | – | Form 8-K (abbv-20240331xexhibit991.htm, filed 2024-04-26) ↗ |
Cite this data
StockData. (2026). AbbVie Qulipta (atogepant) (%), quarterly Q1 2024–Q2 2026 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/qulipta-ww-op-yoy
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.